AbbVie enters $3.8bn deal with Genmab 11-Jun-2020 By Ben Hargreaves The two companies will collaborate on Genmab’s lead bispecific antibody treatment and develop further candidates.
Rentschler enters agreement with Genmab for antibody manufacture 04-Jun-2020 By Ben Hargreaves Rentschler will manufacture Genmab’s bispecific antibodies and expand the US site where the work will take place.
Hired and Retired: Management moves in a time of crisis 08-Apr-2020 By Ben Hargreaves As the pandemic continues to rumble on, biopharma companies have been reshuffling the pack on their executive boards.
Janssen and Genmab hope for repeat success with next-gen agreement 12-Jun-2019 By Ben Hargreaves Genmab agrees deal with Janssen to develop a next-generation mAb product in oncology, which looks to build on the commercial success of the companies’ partnership on Darzalex.